|
[1]
|
Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the treatment of covid-19—preliminary report. reply. N Engl J Med 2020;383(10):994. http://dx.doi.org/10.1056/NEJMc2022236CrossRef
|
|
[2]
|
Wang YM, Zhang DY, Du GH, Du RH, Zhao JP, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020;395(10236):1569 − 78. http://dx.doi.org/10.1016/S0140-6736(20)31022-9CrossRef
|
|
[3]
|
Norrie JD. Remdesivir for COVID-19: challenges of underpowered studies. Lancet 2020;395(10236):1525 − 27. http://dx.doi.org/10.1016/S0140-6736(20)31023-0CrossRef
|
|
[4]
|
Urbach P. Randomization and the design of experiments. Philos Sci 1985;52(2):256 − 73. http://dx.doi.org/10.1086/289243CrossRef
|
|
[5]
|
Rubin DB. Comment: the design and analysis of gold standard randomized experiments. J Am Stat Assoc 2008;103(484):1350 − 53. http://dx.doi.org/10.1198/016214508000001011CrossRef
|
|
[6]
|
Worrall J. Evidence: philosophy of science meets medicine. J Eval Clin Pract 2010;16(2):356 − 62. http://dx.doi.org/10.1111/j.1365-2753.2010.01400.xCrossRef
|
|
[7]
|
Rücker G, Schumacher M. Simpson's paradox visualized: the example of the rosiglitazone meta-analysis. BMC Med Res Methodol 2008;8:34. http://dx.doi.org/10.1186/1471-2288-8-34CrossRef
|
|
[8]
|
Rubin DB. Causal inference through potential outcomes and principal stratification: application to studies with “censoring” due to death. Stat Sci 2006;21(3):299 − 309. http://dx.doi.org/10.1214/088342306000000114CrossRef
|
|
[9]
|
Ding P, Geng Z, Yan W, Zhou XH. Identifiability and estimation of causal effects by principal stratification with outcomes truncated by death. J Am Stat Assoc 2011;106(496):1578 − 91. http://dx.doi.org/10.1198/jasa.2011.tm10265CrossRef
|
|
[10]
|
Wang LB, Zhou XH, Richardson TS. Identification and estimation of causal effects with outcomes truncated by death. Biometrika 2017;104(3):597 − 612. http://dx.doi.org/10.1093/biomet/asx034CrossRef
|
|
[11]
|
Morgan KL, Rubin DB. Rerandomization to improve covariate balance in experiments. Ann Stat 2012;40(2):1263 − 82. |
|
[12]
|
Li XR, Ding P, Rubin DB. Asymptotic theory of rerandomization in treatment–control experiments. Proc Natl Acad Sci USA 2018;115(37):9157 − 62. http://dx.doi.org/10.1073/pnas.1808191115CrossRef
|